Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Innovent Biologics Technology Limited (shanghai R&d Center)

Clinical trials sponsored by Innovent Biologics Technology Limited (shanghai R&d Center), explained in plain language.

Now part of Innovent Biologics, Inc. 1801 HKEX

A Chinese biopharmaceutical company developing and commercializing innovative drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 4 Not yet finished but already full! 2 Completed 1

New drug IBI3032 tested for safety in small human study

Knowledge-focused Completed

This early-phase trial tested the safety and how the body handles a single dose of IBI3032 in 40 healthy adults. Participants were randomly assigned to receive either IBI3032 or a placebo, and some groups also looked at the effect of food on the drug. The study is complete and fo…

Phase: EARLY_PHASE1 • Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) • Aim: Knowledge-focused

Last updated Jun 27, 2026 07:57 UTC